期刊文献+

持续皮下输注与多次皮下注射胰岛素治疗儿童1型糖尿病的meta分析 被引量:7

原文传递
导出
摘要 目的:比较胰岛素泵持续皮下胰岛素输注(CSII)与多次皮下胰岛素注射(MDII)治疗儿童1型糖尿病(T1DM)的疗效。方法:采用PubMed、CNKI等进行检索,检索词包括"胰岛素泵持续皮下胰岛素输注"、"多次皮下胰岛素"、"1型糖尿病"、"儿童";continuous subcutaneous insulin infu-sion by insulin pump,multiple daily insulin injection,搜索CSII组为CSII,MDII组为MDII的随机对照实验。结果:共纳入符合条件文献11篇,共有289例T1DM患儿,其中CSII组143例,MDII组146例。CSII与MDII治疗儿童T1DM所用胰岛素用量的各研究具有较好的异质性(χ2=0.66,P=0.88>0.05),可利用固定效应模型进行分析。CSII与MDII治疗儿童T1DM糖化血红蛋白(HbA1c)、低血糖发生次数的各研究均具有显著的异质性(χ2=13.77,13.93,P均<0.05),利用随机效应模型进行分析。结果显示CSII组的HbA1c、所用胰岛素用量、低血糖发生次数均明显低于MDII组。结论:CSII是一种比较有效治疗儿童糖尿病的方法。
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2012年第18期1508-1510,1512,共4页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献23

二级参考文献146

共引文献73

同被引文献66

  • 1中华医学会糖尿病学分会.中国2型糖尿病防治指南[M].北京:北京大学医学出版社,2010:70. 被引量:85
  • 2S. Rhost,L. L?fbom,J.‐E. M?nsson,A. Lehuen,M. Blomqvist,S. L. Cardell.Administration of Sulfatide to Ameliorate Type I Diabetes in Non‐Obese Diabetic Mice[J].Scand J Immunol.2014(4) 被引量:1
  • 3Finueane OM, Reynolds CM, McGillicuddy FC, et al. Insights into the role of macrophage migration inhibitory factor in obesity and in- sulin resistance[J]. Proc Nutr Soc,2012,71 (4) :622 -633. 被引量:1
  • 4Hoogma RP, Hammond PJ, Gomis R, et al. Comparison of the effects of continuous subcutancous insulin infusion (CSII) and NPH-based multiple daily insulin injections(MDII) on glycaemic control and quality of life : results of the 5-nations trial [ J 1. Diabet Med,2006,23 (2) :141 -147. 被引量:1
  • 5Ranasinghe PD, Maruthur NM, Nicholson WK, et al. Comparative Ef- fectiveness of Continuous Subcutaneous Insulin Infusion Using Insu- lin Analogs and Multiple Daily Injections in Pregnant Women with Diabetes Mellitus: A Systematic Review and Meta-Analysis [ J ]. J Womens Health,2015,24 ( 3 ) :237 - 249. 被引量:1
  • 6Marcus AO. Continuous Subcutaneous Insulin Infusion Therapy with Rapid-Acting Insulin Analogs in Insulin Pumps:Does it Work, How Does it Work,and what Therapies Work Better than Others? [ Jl. Open Diabetes Journal, 2013,6 : 8 - 19. 被引量:1
  • 7S6nchez-Zamora YI, Rodriguez-Sosa M. The role of MIF in type 1 and type 2 diabetes mellitns [ J ]. J Diabetes Res, 2014 (2014) :804519. 被引量:1
  • 8Martin RJ, Savage DA, Carson DJ, et al. Polymorphisms of the macro- phage migration inhibitory factor gene in a UK population with type 1 diabetes me|litus [ J 1 ~ Diabet Med, 2010,27 ( 2 ) : 143 - 149. 被引量:1
  • 9Matia-Gareia I, de ta Cruz-Mosso U, Muhoz-Valle IF, et al. Macro- phage migration inhibitory factor and its relationship with obesity and diabetes[ J~. Invest C1in,2014,55(3) :266 -277. 被引量:1
  • 10Crieb G, Merk M, Bemhagen J,et al. Macmphage migration inhibitory factor (MIF) : a promising biomarker [ J ]. Drug News Perspect, 2010,23(4) :257 -264. 被引量:1

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部